Koch Eye Associates | |
42 Valley Rd, Middletown, RI 02842-6400 | |
(401) 849-4645 | |
Not Available |
Full Name | Koch Eye Associates |
---|---|
Type | Facility |
Speciality | Eyewear Supplier |
Location | 42 Valley Rd, Middletown, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992255236 | NPI | - | NPPES |
CC8793 | Other | RAILROAD MEDICARE |
Mailing Address | Practice Location Address |
---|---|
Koch Eye Associates 175 Paramount Dr, Suite 203, Raynham, MA 02767-1065 Ph: (774) 320-3040 | Koch Eye Associates 42 Valley Rd, Middletown, RI 02842-6400 Ph: (401) 849-4645 |
News Archive
An estimated 33.4 million people worldwide are living with HIV/AIDS, according to a report released Tuesday in Shanghai by the WHO and UNAIDS that shows "more people are living longer due to the availability of drugs," Reuters/Washington Post reports (Rujun/Chan, 11/24).
Researchers from CalciMedica, Inc. and the University of Liverpool today announced the publication of a paper describing positive effects of calcium release-activated calcium (CRAC) channel inhibitors in animal models of acute pancreatitis. The paper, titled "Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of human pancreatic acinar cells and acute pancreatitis in 3 mouse models" appears in the August edition of the journal Gastroenterology.
Weight Watchers International, Inc., the global leader in weight-management services, today announced it has filed a complaint in the U.S. District Court for the Southern District of New York for injunctive relief and damages against Jenny Craig, Inc. ("Jenny Craig").
Kansas Health Institute: "Republicans and Democrats were sharply divided Tuesday over a proposed constitutional amendment that sponsors said would let federal officials know Kansans don't want to be told by the government that they must buy health insurance. On a 12-9, party-line vote, the House Health and Human Services Committee voted to recommend House Concurrent Resolution 5032 favorable for passage.
StemCells, Inc., a leading stem cell company developing and commercializing novel stem cell therapeutics and tools for use in stem cell-based research and drug discovery, today reported financial results and business highlights for the second quarter ended June 30, 2010.
› Verified 9 days ago